Literature DB >> 26251482

Draft Genome Sequences of Burkholderia contaminans, a Burkholderia cepacia Complex Species That Is Increasingly Recovered from Cystic Fibrosis Patients.

Ruhi A M Bloodworth1, Carrie Selin1, Maria Agustina López De Volder2, Pavel Drevinek3, Laura Galanternik4, José Degrossi2, Silvia T Cardona5.   

Abstract

Burkholderia contaminans belongs to the Burkholderia cepacia complex (BCC), a group of bacteria that are ubiquitous in the environment and capable of infecting the immunocompromised and people with cystic fibrosis. We report here draft genome sequences for the B. contaminans type strain LMG 23361 and an Argentinian cystic fibrosis sputum isolate.
Copyright © 2015 Bloodworth et al.

Entities:  

Year:  2015        PMID: 26251482      PMCID: PMC4541265          DOI: 10.1128/genomeA.00766-15

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Burkholderia contaminans (1) is a species of the Burkholderia cepacia complex (BCC), a group of at least 17 species that infect immunocompromised individuals, in particular those with cystic fibrosis (CF) (2, 3). While B. cenocepacia and Burkholderia multivorans are more prevalent in CF patients in the United States and Canada (4), B. contaminans is highly represented in Argentina and Portugal (5, 6), and its incidence is increasing in Spain (7). B. contaminans (1) received its species name in reference to the contamination of a Sargasso Sea DNA sample (8) with the so-called Burkholderia SAR-1 metagenome (9). Intriguingly, B. contaminans has also been found as a contaminant of pharmaceutical products (10, 11). Thus, genome sequence analysis is expected to shed light on whether B. contaminans has an enhanced capacity to survive in harsh environments in comparison with other BCC species that are also isolated from man-made products (12). Here, we used single-molecule real-time (SMRT) sequencing to sequence the genomes of B. contaminans LMG 23361 (1), the type strain for the species, and B. contaminans FFH2055, an isolate from the sputum from a CF patient in Buenos Aires, Argentina. Cultures were grown in LB, and genomic DNA was isolated using phenol-chloroform, as per Sambrook and Russell (13). Sequencing-ready libraries were prepared at the Duke University Genome Sequencing & Analysis Core Resource. DNA sequencing was performed using the PacBio RS II system and yielded 237,907 reads with a mean length of 8.7 kb for LMG23361, and 256,171 reads with a mean read length of 7 kb for FFH2055. The reads were assembled using HGAP (14) (PacBio SMRT Analysis software version 2.3), followed by polishing using Quiver (PacBio). The assembly of LMG23361 consisted of 17 contigs containing 9.2 Mb of sequence, while the FFH2055 assembly contained 8.2 Mb organized into 8 contigs. Species in the genus Burkholderia are known for having large multipart genomes, and the sizes of our assemblies fell within the range of 7.4 to 9.73 Mb seen in previously sequenced genomes (15). Annotation of the assemblies with RAST (16) identified 8,674 and 7,641 open reading frames in LMG23361 and FFH2055, respectively, which fall within the range previously seen in BCC species. LMG23361 contained the complete core genome conserved across the order Burkholderiales (17), while FFH2055 was missing 8 conserved genes. To our knowledge, the draft genome sequence of FFH2055 is the first produced for a B. contaminans strain isolated from a cystic fibrosis patient. This provides a starting point for investigating the emerging prevalence of this new BCC pathogen.

Nucleotide sequence accession numbers.

The B. contaminans LMG23361 and B. contaminans FFH2055 draft genomes have been deposited at DDBJ/EMBL/GenBank under the accession numbers LASD00000000 and LASC00000000, respectively. The versions described in this paper are the first versions, LASD01000000 and LASC01000000.
  16 in total

1.  Incidence of Burkholderia contaminans at a cystic fibrosis centre with an unusually high representation of Burkholderia cepacia during 15 years of epidemiological surveillance.

Authors:  Carla P Coutinho; Celeste Barreto; Luísa Pereira; Luís Lito; José Melo Cristino; Isabel Sá-Correia
Journal:  J Med Microbiol       Date:  2015-05-22       Impact factor: 2.472

Review 2.  Classification and identification of the Burkholderia cepacia complex: Past, present and future.

Authors:  Peter Vandamme; Peter Dawyndt
Journal:  Syst Appl Microbiol       Date:  2011-01-22       Impact factor: 4.022

3.  Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data.

Authors:  Chen-Shan Chin; David H Alexander; Patrick Marks; Aaron A Klammer; James Drake; Cheryl Heiner; Alicia Clum; Alex Copeland; John Huddleston; Evan E Eichler; Stephen W Turner; Jonas Korlach
Journal:  Nat Methods       Date:  2013-05-05       Impact factor: 28.547

Review 4.  Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.

Authors:  P Drevinek; E Mahenthiralingam
Journal:  Clin Microbiol Infect       Date:  2010-07       Impact factor: 8.067

5.  Outbreak of bacteremia due to Burkholderia contaminans linked to intravenous fentanyl from an institutional compounding pharmacy.

Authors:  Rebekah W Moehring; Sarah S Lewis; Pamela J Isaacs; Wiley A Schell; Wayne R Thomann; Mary M Althaus; Kevin C Hazen; Kristen V Dicks; John J Lipuma; Luke F Chen; Daniel J Sexton
Journal:  JAMA Intern Med       Date:  2014-04       Impact factor: 21.873

6.  Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.

Authors:  Elke Vanlaere; Adam Baldwin; Dirk Gevers; Deborah Henry; Evie De Brandt; John J LiPuma; Eshwar Mahenthiralingam; David P Speert; Chris Dowson; Peter Vandamme
Journal:  Int J Syst Evol Microbiol       Date:  2009-01       Impact factor: 2.747

7.  Genetic diversity of Burkholderia contaminans isolates from cystic fibrosis patients in Argentina.

Authors:  Pablo Martina; Marisa Bettiol; Cecilia Vescina; Patricia Montanaro; M Constanza Mannino; Claudia I Prieto; Carlos Vay; Dieter Naumann; Juergen Schmitt; Osvaldo Yantorno; Antonio Lagares; Alejandra Bosch
Journal:  J Clin Microbiol       Date:  2012-11-07       Impact factor: 5.948

8.  Multilocus sequence typing breathes life into a microbial metagenome.

Authors:  Eshwar Mahenthiralingam; Adam Baldwin; Pavel Drevinek; Elke Vanlaere; Peter Vandamme; John J LiPuma; Chris G Dowson
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

Review 9.  Burkholderia cepacia: This Decision Is Overdue.

Authors:  Lynn Torbeck; Diane Raccasi; Dennis E Guilfoyle; Richard L Friedman; David Hussong
Journal:  PDA J Pharm Sci Technol       Date:  2011 Sep-Oct

10.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

View more
  6 in total

1.  Whole Genome Sequence Analysis of Burkholderia contaminans FFH2055 Strain Reveals the Presence of Putative β-Lactamases.

Authors:  José J Degrossi; Cindy Merino; Adela M Isasmendi; Lorena M Ibarra; Chelsea Collins; Nicolás E Bo; Mariana Papalia; Jennifer S Fernandez; Claudia M Hernandez; Krisztina M Papp-Wallace; Robert A Bonomo; Miryam S Vazquez; Pablo Power; María S Ramirez
Journal:  Curr Microbiol       Date:  2019-02-19       Impact factor: 2.188

2.  The first reported case of Burkholderia contaminans in patients with cystic fibrosis in Ireland: from the Sargasso Sea to Irish Children.

Authors:  Rachel F Power; Barry Linnane; Ruth Martin; Noelle Power; Peig Harnett; Brian Casserly; Nuala H O'Connell; Colum P Dunne
Journal:  BMC Pulm Med       Date:  2016-04-22       Impact factor: 3.317

3.  Draft Genome Sequences of Burkholderia contaminans FFI-28, a Strain Isolated from a Contaminated Pharmaceutical Solution.

Authors:  Maria Sol Haim; Marta Mollerach; Gary Van Domselaar; Sergio A Teves; José Degrossi; Silvia T Cardona
Journal:  Genome Announc       Date:  2016-10-27

4.  Improved High-Quality Draft Genome Sequence and Annotation of Burkholderia contaminans LMG 23361T.

Authors:  Ji Young Jung; Youngbeom Ahn; Ohgew Kweon; John J LiPuma; David Hussong; Bernard S Marasa; Carl E Cerniglia
Journal:  Genome Announc       Date:  2017-04-20

5.  Understanding the Pathogenicity of Burkholderia contaminans, an Emerging Pathogen in Cystic Fibrosis.

Authors:  Jaroslav Nunvar; Lucie Kalferstova; Ruhi A M Bloodworth; Michal Kolar; Jose Degrossi; Silvina Lubovich; Silvia T Cardona; Pavel Drevinek
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

6.  Burkholderia cepacia Complex Taxon K: Where to Split?

Authors:  Eliza Depoorter; Evelien De Canck; Charlotte Peeters; Anneleen D Wieme; Margo Cnockaert; James E A Zlosnik; John J LiPuma; Tom Coenye; Peter Vandamme
Journal:  Front Microbiol       Date:  2020-07-14       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.